Papers: 10.1136/jitc-2020-001199

https://doi.org/10.1136/jitc-2020-001199

Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity

Cited by: 4
Author(s): Tae Hee Hong, Hongui Cha, Joon Ho Shim, Boram Lee, Jongsuk Chung, Chung Lee, Nayoung K.D. Kim, Yoon‐La Choi, Soohyun Hwang, Yoomi Lee, Sehhoon Park, Hyun Ae Jung, Jiyeon Kim, Jong‐Mu Sun, Jin Seok Ahn, Myung‐Ju Ahn, Keunchil Park, Se‐Hoon Lee, Woong-Yang Park
Published: about 6 years ago

Software Mentions 1